Suppr超能文献

异维A酸治疗后的安替比林清除率和α1-酸性糖蛋白水平。

Antipyrine clearance and alpha 1-acid glycoprotein levels after isotretinoin.

作者信息

Marsden J R, Shuster S, Dennis J D

出版信息

Hum Toxicol. 1985 May;4(3):335-8. doi: 10.1177/096032718500400317.

Abstract

Eight male subjects aged 18-24 years were treated with 0.5 mg of isotretinoin day-1 kg-1. After 4 weeks levels of cholesterol (P less than 0.05) and triglyceride (P less than 0.05) were increased and levels of high-density lipoprotein (HDL)-cholesterol were decreased (P less than 0.05). Concentrations of aspartate aminotransferase (P less than 0.01) and gamma-glutamyltranspeptidase (P less than 0.01) were higher after treatment; increased alkaline phosphatase and a reduction in bilirubin levels did not reach statistical significance. Values for thyroxine were reduced after isotretinoin and free thyroxine index was lower (P less than 0.01). Measurements of salivary clearance of antipyrine and levels of alpha 1-acid glycoprotein were lower after treatment but these differences did not reach statistical significance. The findings suggest that there is a small decrease in hepatic microsomal-enzyme activity after isotretinoin and that the unwanted effects on lipids, liver and thyroid function are unlikely to be due to hepatic microsomal-enzyme induction.

摘要

8名年龄在18至24岁的男性受试者接受了每日每千克体重0.5毫克异维A酸的治疗。4周后,胆固醇水平(P<0.05)和甘油三酯水平(P<0.05)升高,高密度脂蛋白(HDL)胆固醇水平降低(P<0.05)。治疗后,天冬氨酸转氨酶浓度(P<0.01)和γ-谷氨酰转肽酶浓度(P<0.01)升高;碱性磷酸酶升高和胆红素水平降低未达到统计学显著性。异维A酸治疗后甲状腺素值降低,游离甲状腺素指数较低(P<0.01)。治疗后安替比林唾液清除率测量值和α1-酸性糖蛋白水平较低,但这些差异未达到统计学显著性。研究结果表明,异维A酸治疗后肝微粒体酶活性有小幅下降,对脂质、肝脏和甲状腺功能的不良影响不太可能是由于肝微粒体酶诱导所致。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验